leisure time -WSS

leisure time

author：explore 2025-09-27 16:16:53 - browse：23

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Awakening the world to the whoosh: A patient's crusade

hotspot

WSS

Texas Department of Public Safety speaks out on migrant abuse allegations

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Telehealth startups are trying to fill the menopause care vacuum

'CMA Fest' 2023: How to watch, who is performing and more

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Sanders wants to replace patents with prizes for drug inventions

knowledge

leisure time

entertainment

Peter Hotez and the public health issue of online harassment

After a decade, new Gardasil ad campaign gets it (mostly) right

Alkermes shareholders re

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Tori Bowie and the unacceptable rates of Black maternal death

Tesla recalling nearly 16,000 of its 2021

Hollywood unions extend contract negotiations for actors

Indian pharmaceutical industry in denial over drug

Activists slam private health insurers over coverage restrictions

Indian pharmaceutical industry in denial over drug

knowledge

Why Congress must ban federal programs from using QALYs

Indian pharmaceutical industry in denial over drug

Stanford president faces new allegations over 1999 paper

Awakening the world to the whoosh: A patient's crusade

Delta passengers in Vegas fall sick while waiting on flight in triple

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

focus

hotspot

knowledge

focus